Even if semaglutide and tirzepatide do not meaningfully enter breast milk, GLP-1 therapy during breastfeeding carries indirect risks that deserve serious attention
This reflects the state of play as of early 2026: States that cover GLP-1s for obesity treatment (fee-for-service): Arkansas, Colorado, Connecticut, Delaware, Illinois, Louisiana, Massachusetts, Minnesota, New Mexico, New York, Oregon, Virginia, Washington approximately 13 states total as of January 2026
FAQ Can I get GLP-1s covered if I only want to lose a small amount of weight
The medication works by reducing appetite and making you feel full for longer, but individual experiences can vary
The Wall et al